Acuitas Investments’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,262
Closed -$1.94M 40
2021
Q4
$1.94M Buy
25,262
+9,875
+64% +$871K 0.82% 52
2021
Q3
$1.48M Buy
15,387
+1,642
+12% +$179K 0.65% 62
2021
Q2
$1.47M Buy
13,745
+1,362
+11% +$134K 0.73% 59
2021
Q1
$1.11M Sell
12,383
-1,896
-13% -$209K 0.64% 64
2020
Q4
$1.44M Sell
14,279
-24,708
-63% -$1.84M 0.93% 51
2020
Q3
$1.91M Sell
38,987
-4,493
-10% -$216K 1.33% 39
2020
Q2
$1.78M Buy
+43,480
New +$1.25M 2.23% 20

Other funds holding CRNC

Acuitas Investments's CRNC Position: Q1 2022 in Review

Acuitas Investments sold out of Cerence (CRNC) in Q1 2022, closing a stake of 25,262 shares — an estimated $1.94M sold.

Acuitas Investments first reported a position in CRNC in Q2 2020 and held it in 7 quarters. The position peaked at $1.94M in Q4 2021. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • Acuitas Investments reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • Acuitas Investments sold 25,262 Cerence shares in Q1 2022, an estimated $1.94M.
  • Acuitas Investments first reported a position in Cerence in Q2 2020 and held it in 7 quarters.
  • Acuitas Investments's Cerence position peaked at $1.94M in Q4 2021.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on Acuitas Investments's 13F filing for Q1 2022, filed 6 May 2022.